Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
deals
2
×
life sciences
national blog main
national top stories
roche
alexion pharmaceuticals
alnylam pharmaceuticals
amgen
boehringer ingelheim
boston
cancer
cancer drugs
cobimetinib
dicerna pharamceuticals
fda
hepatitis b
hepatitis b virus
hereditary transthyretin amyloidosis
investing
ipo
patisiran
revolution medicines
rna interference
san francisco
san francisco blog main
san francisco top stories
sanofi
the column group
third rock ventures
university of illinois
venture capital
warp drive bio
world health organization
What
drug
2
×
medicines
research
2
×
cancer
caught
causing
despite
dicerna
disease
eye
family
gene
hardest
hepatitis
hit
hottest
hunters
intended
ipo
pay
pharma
pharmaceuticals
producing
protein
proteins
ras
reels
revolution
roche
stop
targets
team
Language
unset
Current search:
research
×
drug
×
deals
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug